Nextida®
Specific collagen peptide compositions for targeted benefits
Nextida is an innovative platform of specific collagen peptide compositions that deliver targeted health benefits that go beyond those traditionally associated with collagen. Built and backed by science, Nextida unlocks the next generation of unique health solutions.
Think of Nextida as a GPS for the body. Collagen acts as a language, and each peptide composition delivers a specific message. The right collagen peptide composition is like a set of exact coordinates, telling the body how and where to get back to balance.
In 2024, Rousselot launched Nextida GC, the first specific collagen peptide composition from our new Nextida platform. Nextida GC targets post-meal glucose spikes while boosting GLP-1 secretion.
Think of Nextida as a GPS for the body. Collagen acts as a language, and each peptide composition delivers a specific message. The right collagen peptide composition is like a set of exact coordinates, telling the body how and where to get back to balance.
In 2024, Rousselot launched Nextida GC, the first specific collagen peptide composition from our new Nextida platform. Nextida GC targets post-meal glucose spikes while boosting GLP-1 secretion.
Insights
Game-changing collagen solutions
A preventive health solution
Targets a natural mode of action
Efficacy & safety demonstrated in clinical trials
Versatile uses & applications
Knowledge
Decoding the collagen language
By exploring the link between bodily imbalances and specific collagen peptide compositions, our scientists have built a library of 17 targeted compositions designed to naturally help restore balance. Each composition is tested for its impact on body, and the most effective candidates are selected for further trials. Those that successfully complete this process are then launched as branded products within the Nextida range.
Learn how Rousselot's scientists are decoding the collagen languageNext-gen collagen
Nextida GC, the first commercialized composition from this platform
From the library of 17 collagen peptide candidates, one composition demonstrated a remarkable ability to stimulate GLP-1 secretion — a key indicator of enhanced incretin activity.
Following its identification, the composition — now known as Nextida GC — underwent rigorous preclinical and clinical testing to confirm its capacity to naturally promote GLP-1 secretion, and to lower post-meal glucose spikes. These studies validated the initial findings and laid the foundation for its official launch.
With its distinctive collagen peptide profile, Nextida GC represents a promising innovation in the metabolic health space. By supporting natural GLP-1 secretion, it offers the potential to contribute to improved glucose regulation, insulin response, and overall metabolic balance.
Discover Nextida GC and the science behind its benefitsFollowing its identification, the composition — now known as Nextida GC — underwent rigorous preclinical and clinical testing to confirm its capacity to naturally promote GLP-1 secretion, and to lower post-meal glucose spikes. These studies validated the initial findings and laid the foundation for its official launch.
With its distinctive collagen peptide profile, Nextida GC represents a promising innovation in the metabolic health space. By supporting natural GLP-1 secretion, it offers the potential to contribute to improved glucose regulation, insulin response, and overall metabolic balance.
Resources
Additional information
Cracking the collagen code for a healthier future
A groundbreaking innovation shaping the future of collagen peptides
Webinar: Precision where it matters